In The News

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

News tagged ‘MultipleMyeloma’ clear

  • At the American Society of Hematology's annual meeting, Dr. Nikhil Munshi presented results from a study of the antibody BHQ880, which targets DKK-1, a protein that inhibits bone formation and is overabundant in people with multiple myeloma.

Tags: Antibody, BasicResearch, MultipleMyeloma

  • Former “NBC Nightly News” anchor Tom Brokaw, who was diagnosed with multiple myeloma in 2013, toured Dana-Farber and spoke at the Visiting Committee dinner.

     

Tags: MultipleMyeloma

  • A new study suggests earlier treatment of smoldering multiple myeloma may improve survival. Dr. Kenneth Anderson, who was not involved in the research, characterized it as "an important, even paradigm-changing study”.

Tags: BasicResearch, MultipleMyeloma

  • According to Dr. Joseph Antin, it is even more difficult for mixed-race individuals, African-Americans and some subsets of Asian-Americans, particularly South Asians, to find a bone marrow match.

Tags: MultipleMyeloma, Leukemia

  • Co-sponsored by hospital and academic centers, including Dana-Farber, multiple myeloma research advocates will begin providing open Internet access to genetic and research data on hundreds of patients.

Tags: BasicResearch, MultipleMyeloma

  • Kathy Giusti, a Dana-Farber patient and founder of the Multiple Myeloma Research Foundation, and Dr. John Quakenbush comment on Boston's prominence in the world of biotech research.

Tags: MultipleMyeloma

  • A new study conducted by scientists from Dana-Farber Cancer Institute and Karolinska Institutet in Sweden, presents very promising results for the treatment of multiple myeloma.

Tags: chemotherapy, MultipleMyeloma

  • Dr. Paul Richardson led a study showing treatment with an investigational oral drug led to stable disease or better response in three fourths of patients with heavily pretreated multiple myeloma.

Tags: MultipleMyeloma

  • Dr. Paul Richardson presented recent Phase 2 clinical trial results at the International Myeloma Workshop in Kyoto, Japan.

Tags: MultipleMyeloma

  • Dr. Ken Anderson discusses new targeted medicines for the treatment of myeloma. Dr. Anderson is leading an international study to determine whether these new drugs could mean risky transplants aren't needed any more.

Tags: MultipleMyeloma, TargetedTherapy

Showing 1-10 of 13 items